PATENT CLAIM ANALYSIS

Application Number: 16143748
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-05
Patent Classification: ["424", "001890"]

Abstract:
The present disclosure is directed, in part, to compounds and methods for imaging myocardial perfusion, comprising administering to a patient a contrast agent which comprises a compound that binds MC-1, and an imaging moiety, and scanning the patient using diagnostic imaging.

Claim (Index 28):
The contrast agent of  claim 27  wherein the paramagnetic species for use in MRI imaging is Gd 3+ , Fe 3+ , In 3+ , or Mn 2+ .

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.34286
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13529756', '15153502', '14845320', '12014161', '15629068']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8121572316163038
- 35 USC 102 Novelty (BERT): 0.5738010800436296
- Combined Prediction Score: 0.7883216164590364
- Mean Citation Score: 365.333556
- Max Citation Score: 434.32803
- Similarity Product: 276.1070865895629

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test